![Henri Theunissen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henri Theunissen
Algemeen Directeur bij BioMedbooster BV
Actieve functies van Henri Theunissen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioMedbooster BV
![]() BioMedbooster BV Miscellaneous Commercial ServicesCommercial Services BioMedbooster BV provides valorization services. It supports businesses in translating their inventions or ideas into products ready for marketing. The company builds bridges between scientific research and industry, especially in life sciences and biomedical technologies. The firm offers evaluation of commercial potential of the invention, market analysis, managing the patenting process, business plan development, financial support for patent application in selected cases, business development financing, finding seed capital, monitoring contracts and payments, strong connections in scientific, industrial and financial communities, finding licensees and monitoring patent infringement. BioMedbooster was founded in 2005 and is headquartered in Maastricht, the Netherlands. | Algemeen Directeur | 01-11-2009 | - |
Loopbaan van Henri Theunissen
Eerdere bekende functies van Henri Theunissen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Directeur/Bestuurslid | - | - |
Diosynth RTP, Inc.
![]() Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Corporate Officer/Principal | - | - |
Nobilon International BV | Corporate Officer/Principal | - | - |
Organon International BV | Corporate Officer/Principal | - | - |
Opleiding van Henri Theunissen
Radboud University Nijmegen | Undergraduate Degree |
University of Amsterdam | Doctorate Degree |
Statistieken
Internationaal
Nederland | 7 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
BioMedbooster BV
![]() BioMedbooster BV Miscellaneous Commercial ServicesCommercial Services BioMedbooster BV provides valorization services. It supports businesses in translating their inventions or ideas into products ready for marketing. The company builds bridges between scientific research and industry, especially in life sciences and biomedical technologies. The firm offers evaluation of commercial potential of the invention, market analysis, managing the patenting process, business plan development, financial support for patent application in selected cases, business development financing, finding seed capital, monitoring contracts and payments, strong connections in scientific, industrial and financial communities, finding licensees and monitoring patent infringement. BioMedbooster was founded in 2005 and is headquartered in Maastricht, the Netherlands. | Commercial Services |
Organon International BV | |
Diosynth RTP, Inc.
![]() Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Health Technology |
Nobilon International BV | |
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Health Technology |
- Beurs
- Insiders
- Henri Theunissen
- Ervaring